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A concise synthesis of the marine alkaloids (–)-lepadins A–C 5 
from a phenylglycinol-derived tricyclic lactam is reported. 
Key steps from the stereochemical standpoint involve 
stereoselective cyclocondensation, double bond 
hydrogenation, oxazolidine opening, hydroboration-
oxidation, and Horner-Wadsworth-Emmons reactions. 10 
The lepadin alkaloids are a small group of cis-
decahydroquinoline alkaloids isolated during the period 1991-
2002 from different marine sources such as the tunicate Clavelina 
lepadiformis1 and its predator the flatworm Prostheceraeus 
villatus,1b as well as the Australian Great Barrier Reef tunicate 15 
Didemnun sp.2 and ascidian Aplidium tabascum.3   Structurally, 
all of them incorporate a methyl substituent at the C-2 position of 
the decahydroquinoline nucleus, a functionalized eight-carbon 
chain at C-5, and a free or acylated hydroxy group at C-3. 
However, they display a diversified array of relative 20 
stereochemical relationships (Fig 1). Lepadins A and B have been 
shown to exhibit significant in vitro cytotoxicity against several 
human cancer cell lines.1b In addition, lepadin B is a potent 
blocker for neuronal nicotinic acetylcholine receptors.4 Lepadins 
D–F have low cytotoxicity but significant and selective 25 
antiplasmodial and antitrypanosomal activity.2 Further 
pharmacological research on these alkaloids has been hampered 
by the low quantities of samples available from natural sources. 
This has stimulated considerable synthetic effort in this area,5 
although the development of facile enantioselective routes to 30 
lepadins or synthetic analogs is still required. 
 
Fig. 1 Lepadin alkaloids. 
 
 In the context of our studies6 on the use of phenylglycinol-35 
derived chiral tricyclic lactams for the enantioselective synthesis 
of alkaloids, we present herein a straightforward synthesis of (–)-
lepadins A–C. 
Our approach takes advantage of unsaturated tricyclic lactams 
B, functionalized platforms that are assembled in a 40 
straightforward manner by a cyclocondensation reaction between 
(R)-phenylglycinol and an appropriate cyclohexenone-derived δ-
keto ester A. As outlined in Scheme 1, the synthesis of lepadins 
A–C from lactams B would involve (i) the stereoselective 
hydrogenation of the C–C double bond to obtain the required 45 
configuration at C-5, (ii) the stereoselective opening of 
oxazolidine ring to give the natural cis-decahydroquinoline 
stereochemistry, (iii) the stereoselective introduction of the C-2 
methyl and C-3 hydroxy substituents, taking advantage of the 
lactam carbonyl, and (iv) the elongation of the C-5 side chain.  50 
 
 
Scheme 1 Synthetic strategy. 
 55 
As a model system for evaluating the viability of our strategy, 
we selected the known6 lactam 1, which lacks the functionalized 
carbon chain at C-5 but bears a methyl substituent instead. 
Slightly disappointingly, reductive cleavage of the oxazolidine 
C–O bond using Et3SiH/TiCl4 took place with only moderate 60 
stereoselectivity, leading to decahydroquinolone 2a as a 5:1 
mixture of cis/trans epimers. A great improvement was achieved 
by using LiAlH4/AlCl3 as the reductant, cis-decahydroquinoline 
2b being stereoselectively obtained under these conditions. 
Although alane additionally caused the reduction of the lactam 65 
carbonyl, this functionality was satisfactorily reinstalled, after N-
debenzylation with simultaneous N-Boc protection, by 
ruthenium-promoted oxidation7 of N-Boc derivative 3 (Scheme 
2). From the resulting N-protected lactam 4, the introduction of  
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Scheme 2 Model studies. Reagents and conditions: (a) LiAlH4, AlCl3, 
THF, 0 ºC, 30 min; then –78 ºC, 1.5 h and rt, 3 h, 79%; (b) H2, 
Pd(OH)2, (Boc)2O,  MeOH, rt, 20 h, 72%; (c) RuCl3·nH2O, NaIO4, 5 
CCl4-CH3CN-H2O, 0 ºC, 5 min, then rt 1 h, 73%; (d) LiHMDS, THF, –
78 ºC, 2 h; 5-Cl-2-NTf2-Pyr, THF, then rt, 1.5 h, 95%; (e) CuI, MeLi, 
THF, –20 ºC, 30 min, –78 ºC, then rt, 16 h; (f) BH3·SMe2, THF, –78 ºC, 
then rt, 16 h, then Me3NO·2H2O, THF, reflux, 45 min, 78% (steps e-f). 
 10 
the C-2 methyl substituent was accomplished via the 
corresponding vinyl triflate, prepared by the Comins’ protocol, 
by reaction with lithium dimethylcuprate.8 With enecarbamate 
5 in hand, hydroboration with the BH3·SMe2 complex
9 and 
subsequent oxidation of the intermediate borane with 15 
trimethylamine N-oxide10 stereoselectively provided alcohol 6 
in excellent overall yield. The facial selectivity, with exclusive 
formation of the H-2/H-8a cis isomer, was not unexpected as it 
involves the syn addition of borane from the less hindered face 
of the double bond, via a transition state in which the C8–C8a 20 
bond is axially oriented to avoid the A(1,3) strain (Fig 2).  
 
 
Fig. 2 Stereoselectivity of the hydroboration reaction. 
 25 
The application of the above strategy to the synthesis of (–)-
lepadins A–C required starting from a tricyclic lactam bearing a 
functionalized carbon chain, for instance a protected 
hydroxymethyl substituent, at the 5 position of the quinoline 
ring. The overall synthetic sequence is outlined in Scheme 3. 30 
Such a lactam, 8, was prepared in two steps by 
cyclocondensation of δ-keto ester 711 with (R)-phenylglycinol 
followed by catalytic hydrogenation of the resulting  
unsaturated tricyclic lactams.12 The conversion of 8, which 
possesses the appropriate configuration at the 4a and 5 35 
positions of the hydroquinoline ring, to alcohol 12 was carried 
out in satisfactory overall yield as in the above model series. 
However, the trimethylsilylethyl (TMSE) protecting group had 
to be replaced by TIPS to avoid its oxidation to 
trimethylsilylacetyl during the ruthenium–mediated oxidation 40 
step.13 Thus, LiAlH4/AlCl3 reduction of 8, followed by 
BF3·Et2O–promoted deprotection and hydrogenolysis of the 
benzylic C–N bond in the presence of (Boc)2O gave cis-
decahydroquinoline 9. After reprotection of the hydroxyl group 
as a TIPS derivative, the ruthenium oxidation step took place in 45 
nearly quantitative yield to give lactam 10, which was 
efficiently converted to enecarbamate 11 via a triflate, and then 
to alcohol 12 by stereoselective hydroboration–oxidation. 
The next step was to install the correct C-3 absolute 
configuration. As anticipated, complete inversion of the C-3 50 
stereochemistry was accomplished (83% overall yield) by 
Dess-Martin oxidation of alcohol 12 followed by NaBH4 
reduction, with hydride delivery from the more accessible face  
 
N
H
H
Boc
O
NH2
OH
C6H5 R N
H
O
C6H5
OMeO2C
OTMSE
OTMSE
N
H
H
Boc
HO
N
H
H
Boc
OH
N
H
H
Boc
OTIPS
O
OTIPS
OTIPS
N
H
H
Boc
HO
OTIPS
N
H
H
Boc
AcO
H
a,b
r
+
f, gh, i
j
k, l m, n, o
O
p
N
H
H
HO
N
H
H
HO
( )-Lepadin C
O
O
H
N
H
H
O
O
ref 5d
c,d,e
OH
O
7 8
11 10 9
12 13 14
BocBoc
q
18
ref.5b,d
16
( )-Lepadin A ( )-Lepadin B
55 
Scheme 3: Enantioselective synthesis of (–)-lepadins A–C. Reagents and 
conditions: (a) AcOH, benzene, reflux, 72 h; (b) H2, Pt2O, MeOH, 5 h, 
67% (steps a-b); (c) LiAlH4, AlCl3, THF, 0 ºC, 30 min; then –78 ºC, 1.5 h 
and rt, 3 h, 76%; (d) BF3·Et2O, CH2Cl2, 0 ºC, then rt, 2 h; (e) H2, Pd(OH)2, 
(Boc)2O, MeOH, rt, 20 h, 79% (steps d-e); (f) TIPSCl, imidazole, DMF, 60 
16 h, 93%; (g) RuCl3·nH2O, NaIO4, CCl4-CH3CN-H2O, 0 ºC, 5 min, then 
rt 1h, 97%; (h) LiHMDS, THF, –78 ºC, 2 h; 5-Cl-2-NTf2-Pyr, THF, then 
rt, 2.5 h, 90%; (i) CuI, MeLi, THF, –20 ºC, 30 min, –78 ºC, then rt, 16 h; 
(j) BH3·SMe2, THF,  –78 ºC, then rt, 16 h, then Me3NO·2H2O, THF, 
reflux, 45 min, 81% (steps i-j); (k) Dess-Martin, CH2Cl2, rt, 2.5 h; (l) 65 
NaBH4, MeOH, –40 ºC, 16 h, 84% (steps k-l); (m) Ac2O, DMAP, Et3N, 
CH2Cl2, 0 ºC, then rt, 3 h, 91%; (n) TBAF, AcOH, 30-40 ºC, 24 h, 83%; 
(o) Dess-Martin, CH2Cl2, rt, 3 h; (p) KHMDS, (E)-C4H9–CH=CH–
CH2P(O)(OEt)2 (15), THF, –78 ºC, 16 h, 68% (steps n-p); (q) TFA, 
CH2Cl2, 0 ºC, then rt, 1 h, 99%; (r) NaHMDS, (E)-MeC(O2C2H4)(CH2)2–70 
CH=CH–CH2P(O)(OEt)2 (17), DME, –78 ºC, 57%. 
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of the ketone carbonyl. The resulting alcohol 13 has the same 
absolute configuration as lepadins A–C at the five stereogenic 
centers of the decahydroquinoline ring. After protection of the 
hydroxy group as an acetate, removal of the TIPS protecting 
group and subsequent Dess-Martin oxidation led to aldehyde 5 
14, which was used in the next step without purification.  
Finally, for the elongation of the C-5 side chain to install the 
octadienyl moiety present in lepadins A-C and ensure the 
required E,E stereochemistry, we selected the Horner-
Wadsworth-Emmons methodology using an appropriate E-10 
configurated phosphonate. Thus, reaction of aldehyde 14 with 
the anion derived from diethyl (E)-hept-2-enylphosphonate 
(15),14 which occurred with concomitant hydrolysis of the 
acetate ester, gave alcohol 16. The synthesis of (–)-lepadin B 
was completed by cleaving the Boc protecting group. The 15 
preparation of alcohol 16 also represents a formal total 
synthesis of (–)-lepadin A.5b,d Similarly, the (E,E)-7-oxoocta-
1,3-dienyl side chain of (–)-lepadin C was stereoselectively 
assembled by reaction of aldehyde 14 with diethyl (E)-6,6-
(ethylenedioxy)hept-2-enylphosphonate (17),5d leading to 20 
alcohol 18, a known5d synthetic precursor of (–)-lepadin C. 
In summary, we have developed a concise route to (–)-
lepadins A–C using a phenylglycinol-derived lactam as the 
starting enantiopure scaffold, which allows the stereocontrolled 
generation of the five stereogenic centers on the 25 
decahydroquinoline ring. Our synthesis (lepadin B: 17 steps; 
11.3% overall yield from 7) compares advantageously in terms 
of both overall yield and number of synthetic steps with 
previous syntheses of these alkaloids. Inversion of the 
configuration at C-5 in the intermediate aldehyde 14 could 30 
provide access to other members of this family of natural 
products. 
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